Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

NCT05686447 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT05686447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05686447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Lead sponsor
Zhujiang Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
July 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

m-protein, monoclonal gammopathies, multiple myeloma